Cargando…
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
The emergence of highly transmissible SARS-CoV-2 variants of concern (VOCs) that are resistant to therapeutic antibodies highlights the need for continuing discovery of broadly reactive antibodies. We identified four receptor binding domain–targeting antibodies from three early-outbreak convalescent...
Ejemplares similares
-
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
por: Wang, Lingshu, et al.
Publicado: (2021) -
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
por: Cho, Hyeseon, et al.
Publicado: (2021) -
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
por: Zhou, Tongqing, et al.
Publicado: (2022) -
T cell immunity to SARS-CoV-2 following natural infection and vaccination
por: DiPiazza, Anthony T., et al.
Publicado: (2021) -
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
por: Lima, Noemia S., et al.
Publicado: (2022)